Boot Beginnings

The brand arrived on the British high street in the 1960s thanks to the Griggs family, who snapped up the license for the 1460 eight-eyelet boots created by a German army doctor named Klaus Märtens. Adopted by successive tribes of music fans, including skinheads and punks, while becoming a staple of the English soccer terrace in the 1980s, the boot became a symbol of rebellious youth culture. The Griggs family left the company in 2013, selling their 91.5 percent stake to Permira for $410 million, and the private equity house worked to connect the brand with its roots while appealing to new generations.

Dr. Martens expanded to sell 11 million pairs of shoes every year in over 60 countries, and it brought the numerous strands of its heritage together when it opened a flagship in gritty but cool Camden in north London rather than the West End. The store includes a venue to showcase unsigned bands to promote its musical roots.

Dr. Martens has been busy but careful in expanding its store network internationally. It now has around 240 owned stores internationally, with about a quarter of those in the U.S. and the others spread chiefly around the U.K., Germany, France, and Italy.

Doc Martens Stumbles

It all looked so promising, and in 2021, Dr. Martens engaged Goldman Sachs and Morgan Stanley as joint global coordinators, and Barclays, HSBC, Merrill Lynch, and RBC Europe as joint book-runners for a stock exchange listing. But that’s not quite how it worked out. Anyone who invested in its IPO would currently have seen over 85 percent of the equity wiped out amid a slew of profit warnings and investor unease about the firm’s management. The bootmaker unveiled a turnaround plan last summer, which involved reducing its reliance on discounting across the business, targeting new markets, and promoting new products, such as bags and sandals.

The investors who paid top dollar for Dr. Martens have been questioning whether a heritage footwear brand built around rebellious youth culture, encompassing everything from sports to music, could maintain premium pricing in an increasingly promotional environment. Now, however, the company’s turnaround is beginning to show some signs of credibility.

The latest annual results showed adjusted pre-tax profit jumping 61.3 percent to about $74.3 million, while adjusted EBIT rose more than 30 percent to roughly $107.1 million. Importantly, those gains came despite revenue falling 2.9 percent to around $1.03 billion, reflecting a deliberate strategy to prioritize margin quality over chasing sales volume through discounting. That distinction matters because the recovery at Dr. Martens has not been built on financial engineering or temporary cost-cutting alone. Instead, its latest results reflect a broader repositioning of the business around brand discipline, consumer engagement, and operational simplification under CEO Ije Nwokorie.

Last summer, he described 2026 as a “year of pivot, as we make the necessary changes to our business to set us up for future sustainable growth. I remain laser focused on executing our new strategy.” The company describes its shift as a move from a channel-led business to a consumer-first operating model. In practice, that has meant pulling back hard from the discounting culture that had started to erode the brand’s premium positioning, particularly in the U.S. wholesale market.

Doc Martens in America

The U.S. has become both Dr. Martens’ greatest growth opportunity and its biggest operational headache. Wholesale partners spent the past two years destocking as post-pandemic demand cooled and consumers became more cautious. The result was excess inventory, rising promotions, and weakening brand equity.

In its latest figures, off-price sales in U.S. wholesale fell 31 percent, while full-price direct-to-consumer revenue climbed 14 percent. Gross margin improved by 120 basis points to 66.2 percent, helped by tighter inventory control and a better full-price sales mix. For a business whose biggest challenge had become overexposure and discount dependency, those figures are arguably more significant than the headline profit rebound.

Nwokorie’s strategy has effectively reversed that cycle by shrinking off-price activity and rebuilding demand around core products. The company said “green shoots” were emerging around full-price sales of its famous 1460 boot in the U.S., while analysts have highlighted stronger retail momentum and cleaner inventory levels.

Even its small recent recovery, from near all-time lows, has failed to put much of a dent in long-term losses, but the share price at least appears to have stabilized and begun a slow drift upwards. While analysts have been broadly supportive of the firm’s long-term strategy, many remain worried about execution risks: “Protecting the integrity of the brand rather than flogging its footwear on the cheap is a sensible long-term approach,” Dan Coatsworth, head of markets at AJ Bell, said at the start of the year. 

Efficiency Meets Authenticity

Part of the revival has been driven by fashion’s ongoing focus on authenticity; Dr. Martens has benefited from being viewed as timeless rather than trendy, giving the brand a sense of permanence that resonates with a younger consumer base increasingly interested in durability and versatility.

Gen Z shoppers have become especially important. Unlike earlier generations who discovered Dr. Martens through music and sports, younger buyers are often discovering the brand through social media influencers, vintage styling videos, and celebrity endorsements. Platforms such as TikTok and Instagram have turned the boots into a staple of contemporary streetwear, frequently paired with oversized tailoring, baggy denim, and gender-neutral fashion, and leveraging the rise of quiet durability, where consumers buy fewer but longer-lasting products.

Dr. Martens has also successfully repositioned itself through collaborations, fashion-led campaigns, and lighter silhouettes aimed at female consumers. And geographically, the resurgence has been particularly strong in North America, where younger consumers have embraced the brand as part of a broader revival in workwear-inspired and heritage fashion.

Product Mix Crucial

One of the most important aspects of the current recovery has been broadening the product mix beyond the classic boot category. Shoes were the standout performer during financial year 2026, with revenues up 19 percent, while newer product families, including Lowell, Buzz, and Zebzag accounted for 9 percent of total pairs sold, triple their contribution a year earlier. At the same time, the company has maintained strong momentum around its established hero products, including the 1461 shoe, Adrian loafer, and Mary Jane lines.

The pivot toward direct-to-consumer retail, enhanced flagship stores, and brand-led environments has given the company greater influence over how the brand is presented. The positive reaction to its new Brewer Street store in central London has become symbolic of that strategy. Nwokorie said that the store, the company’s largest and one he describes as a ‘beacon,’ has demonstrated growing consumer excitement around the brand and increased interest from collaborators and wholesale partners alike.

Dr. Martens in Recovery

Despite ongoing tariff and transportation pressures, management says it currently has no plans for significant price hikes, instead focusing on margin protection through operational efficiency and sales mix improvement.  That restraint may prove important in an uncertain consumer environment as the company acknowledges that Europe remains challenging, with consumers in the U.K. and Germany proving to be more promotion-driven than their American counterparts. By pulling back, simplifying the business, and focusing on full-price demand, management has finally put its best foot forward.